OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial
Robert S. Wallis, Sibuse Ginindza, Trevor Beattie, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 8, pp. 897-908
Open Access | Times Cited: 93
Robert S. Wallis, Sibuse Ginindza, Trevor Beattie, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 8, pp. 897-908
Open Access | Times Cited: 93
Showing 26-50 of 93 citing articles:
Host-directed therapies in pulmonary tuberculosis: Updates on anti-inflammatory drugs
Juan M. Cubillos-Angulo, Betânia M. F. Nogueira, María B. Arriaga, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 23
Juan M. Cubillos-Angulo, Betânia M. F. Nogueira, María B. Arriaga, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 23
Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial
Gail Brenda Cross, Intan Permata Sari, Cissy Kityo, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 7, pp. 847-855
Closed Access | Times Cited: 15
Gail Brenda Cross, Intan Permata Sari, Cissy Kityo, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 7, pp. 847-855
Closed Access | Times Cited: 15
The advances in adjuvant therapy for tuberculosis with immunoregulatory compounds
Jie Mi, Xueqiong Wu, Jianqin Liang
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 5
Jie Mi, Xueqiong Wu, Jianqin Liang
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 5
Targeting Molecular Inflammatory Pathways in Granuloma as Host-Directed Therapies for Tuberculosis
Reto Guler, Mumin Ozturk, Solima Sabeel, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 31
Reto Guler, Mumin Ozturk, Solima Sabeel, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 31
The immune response in tubercular uveitis and its implications for treatment: From anti-tubercular treatment to host-directed therapies
Ikhwanuliman Putera, Benjamin Schrijver, Josianne C. ten Berge, et al.
Progress in Retinal and Eye Research (2023) Vol. 95, pp. 101189-101189
Open Access | Times Cited: 11
Ikhwanuliman Putera, Benjamin Schrijver, Josianne C. ten Berge, et al.
Progress in Retinal and Eye Research (2023) Vol. 95, pp. 101189-101189
Open Access | Times Cited: 11
Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease
Alex Kayongo, Brian Nyiro, Trishul Siddharthan, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11
Alex Kayongo, Brian Nyiro, Trishul Siddharthan, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 11
Harnessing host-pathogen interactions for innovative drug discovery and host-directed therapeutics to tackle tuberculosis
Sapna Saini, Anjali Gangwar, Rashmi Sharma
Microbiological Research (2023) Vol. 275, pp. 127466-127466
Open Access | Times Cited: 11
Sapna Saini, Anjali Gangwar, Rashmi Sharma
Microbiological Research (2023) Vol. 275, pp. 127466-127466
Open Access | Times Cited: 11
A scoping review of interventions to address TB associated respiratory disability
Cassandra Mbanje, Isla Kuhn, Nozipho Musakwa, et al.
EClinicalMedicine (2024) Vol. 73, pp. 102646-102646
Open Access | Times Cited: 4
Cassandra Mbanje, Isla Kuhn, Nozipho Musakwa, et al.
EClinicalMedicine (2024) Vol. 73, pp. 102646-102646
Open Access | Times Cited: 4
Leprosy
Marlous L. Grijsen, Thuan Nguyen, Roberta Olmo Pinheiro, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 4
Marlous L. Grijsen, Thuan Nguyen, Roberta Olmo Pinheiro, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 4
High throughput screening assay for the identification of ATF4 and TFEB activating compounds
Daniel Pfau, Ruslana Bryk
Autophagy Reports (2025) Vol. 4, Iss. 1
Open Access
Daniel Pfau, Ruslana Bryk
Autophagy Reports (2025) Vol. 4, Iss. 1
Open Access
Alveolar macrophages: novel therapeutic targets for respiratory diseases
Pamelia N. Lim, Maritza M. Cervantes, Linh K. Pham, et al.
Expert Reviews in Molecular Medicine (2021) Vol. 23
Closed Access | Times Cited: 24
Pamelia N. Lim, Maritza M. Cervantes, Linh K. Pham, et al.
Expert Reviews in Molecular Medicine (2021) Vol. 23
Closed Access | Times Cited: 24
Azithromycin as host-directed therapy for pulmonary tuberculosis – a randomized pilot trial
Bart G. J. Dekkers, Huib A.M. Kerstjens, Helene W. Breisnes, et al.
The Journal of Infectious Diseases (2025)
Closed Access
Bart G. J. Dekkers, Huib A.M. Kerstjens, Helene W. Breisnes, et al.
The Journal of Infectious Diseases (2025)
Closed Access
PDE4B Modulates Phosphorylation of p65 (Ser468) via cAMP/PKA in Acute Lung Injury
Rana Dhar, Yajun Li, Zhengqiang Hu, et al.
Lung (2025) Vol. 203, Iss. 1
Closed Access
Rana Dhar, Yajun Li, Zhengqiang Hu, et al.
Lung (2025) Vol. 203, Iss. 1
Closed Access
Increased autophagy activity regulated by LC3B gene promoter DNA methylation is associated with progression to active pulmonary tuberculosis disease
Yung-Che Chen, Ying-Tang Fang, Chao-Chien Wu, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Yung-Che Chen, Ying-Tang Fang, Chao-Chien Wu, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Post-tuberculosis lung disease: towards prevention, diagnosis, and care
Jamilah Meghji, Sara C. Auld, Gregory P. Bisson, et al.
The Lancet Respiratory Medicine (2025)
Closed Access
Jamilah Meghji, Sara C. Auld, Gregory P. Bisson, et al.
The Lancet Respiratory Medicine (2025)
Closed Access
Microenvironments of tuberculous granuloma: advances and opportunities for therapy
G. R. F. Krueger, Shah Faisal, Anca Dorhoi
Frontiers in Immunology (2025) Vol. 16
Open Access
G. R. F. Krueger, Shah Faisal, Anca Dorhoi
Frontiers in Immunology (2025) Vol. 16
Open Access
High rates of post-tuberculosis lung disease among persons successfully treated for drug-susceptible and resistant tuberculosis
Russell R. Kempker, Argita D. Salindri, Teona Avaliani, et al.
Thorax (2025), pp. thorax-222350
Closed Access
Russell R. Kempker, Argita D. Salindri, Teona Avaliani, et al.
Thorax (2025), pp. thorax-222350
Closed Access
Understanding the tuberculosis granuloma: the matrix revolutions
Paul Elkington, Marta E. Polak, Michaela T. Reichmann, et al.
Trends in Molecular Medicine (2021) Vol. 28, Iss. 2, pp. 143-154
Open Access | Times Cited: 23
Paul Elkington, Marta E. Polak, Michaela T. Reichmann, et al.
Trends in Molecular Medicine (2021) Vol. 28, Iss. 2, pp. 143-154
Open Access | Times Cited: 23
Modulating macrophage function to reinforce host innate resistance against Mycobacterium avium complex infection
Hyun-Eui Park, Wonsik Lee, Sang‐Won Choi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Hyun-Eui Park, Wonsik Lee, Sang‐Won Choi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Exploring and exploiting the host cell autophagy during Mycobacterium tuberculosis infection
Pavan Kumar Nagdev, Puja Kumari Agnivesh, Arnab Roy, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2023) Vol. 42, Iss. 11, pp. 1297-1315
Closed Access | Times Cited: 8
Pavan Kumar Nagdev, Puja Kumari Agnivesh, Arnab Roy, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2023) Vol. 42, Iss. 11, pp. 1297-1315
Closed Access | Times Cited: 8
Advances in an In Vitro Tuberculosis Infection Model Using Human Lung Organoids for Host-Directed Therapies
Seung-Yeon Kim, Jiae Choi, Seri Choi, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 7, pp. e1012295-e1012295
Open Access | Times Cited: 3
Seung-Yeon Kim, Jiae Choi, Seri Choi, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 7, pp. e1012295-e1012295
Open Access | Times Cited: 3
Leveraging insights from cancer to improve tuberculosis therapy
Meenal Datta, Laura E. Via, Véronique Dartois, et al.
Trends in Molecular Medicine (2024)
Open Access | Times Cited: 3
Meenal Datta, Laura E. Via, Véronique Dartois, et al.
Trends in Molecular Medicine (2024)
Open Access | Times Cited: 3
Pathogenesis of Post-Tuberculosis Lung Disease: Defining Knowledge Gaps and Research Priorities at the 2nd International Post-Tuberculosis Symposium
Sara C. Auld, Amy K. Barczak, William R. Bishai, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 8, pp. 979-993
Closed Access | Times Cited: 3
Sara C. Auld, Amy K. Barczak, William R. Bishai, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 8, pp. 979-993
Closed Access | Times Cited: 3
Shedding Light on Autophagy During Human Tuberculosis. A Long Way to Go
Joaquín Miguel Pellegrini, Nancy Liliana Tateosian, María Paula Morelli, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 14
Joaquín Miguel Pellegrini, Nancy Liliana Tateosian, María Paula Morelli, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 14
Recent Advances in Host-Directed Therapies for Tuberculosis and Malaria
Kely Catarine Matteucci, André A. S. Correa, Diego L. Costa
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 12
Kely Catarine Matteucci, André A. S. Correa, Diego L. Costa
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 12
